Aberrant expression of MAM proteins is commonly observed in tumors, where changes in the cellular microenvironment are often associated with the activation of transmembrane receptors and Ca2+‐permeable channels involved in cancer progression, epithelial–mesenchymal transition, invasion, and resistance to apoptosis [226]. Here, SGCG is linked to cancer.